Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Z. V. Konova"'
Publikováno v:
Russian journal of hematology and transfusiology. 67:551-569
Introduction.Currently, more and more attention is being paid to possible strategies for preventing the development of graft-versus-host disease (GVHD) and reducing the risk of infections while maintaining the antitumor effect — graft-versus-leukem
Autor:
M. Yu. Drokov, Yu. O. Davydova, V A Vasilyeva, Z V Konova, Nikolay M. Kapranov, Irina V. Galtseva, Elena N. Parovichnikova, Larisa A. Kuzmina, V G Savchenko
Publikováno v:
Russian journal of hematology and transfusiology. 66:539-555
Introduction. One of the main causes of treatment failure after allogeneic hematopoietic stem cells transplantation (alloHSCT) for acute leukemia (AL) is disease relapse. In recent years, multiparameter fl ow cytometry (MPC) has been widely used to d
Autor:
V A Vasilyeva, Elmira I. Kolgaeva, I N Subortseva, Z V Konova, Dmitry I. Chebotarev, T V Gaponova, Mariya V. Dovydenko, Alla M. Kovrigina, Valerii G. Savchenko, Larisa A. Kuzmina, Anait L. Melikyan, Elena N. Parovichnikova, Mikhail Yu. Drokov, Denis V. Kamelskih, Sokolova Ma, Mikhail Maschan
Publikováno v:
Терапевтический архив, Vol 93, Iss 7, Pp 805-810 (2021)
Indications of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with primary myelofibrosis are intermediate-2 and high-risk group of DIPSS (Dynamic International Prognostic Scoring System), beginning of the disease in childh
Autor:
M. Yu. Drokov, Z V Konova, Vera Vasilieva, N N Popova, T.A. Tupoleva, Ekaterina Mikhaltsova, Larisa A. Kuzmina, G. A. Klyasova, Olga Koroleva, Elena N. Parovichnikova, V G Savchenko, Dmitry S. Tikhomirov, D S Dubnyak
Publikováno v:
Clinical Microbiology and Antimicrobial Chemotherapy. 20:232-238
Incidence, severity, and risk factors for hemorrhagic cystitis (HC) were assessed in 267 patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). HC was diagnosed in 14.6% (39 patients) within 1-139 days after allo-HSCT (me
Autor:
Z V Konova, Valeriy G. Savchenko, V A Vasilyeva, Irina V. Galtseva, Hunan Julhakyan, Mikhail Drokov, Julia O. Davydova, Elena N. Parovichnikova, Sergey M. Kulikov, Larisa A. Kuzmina, Nikolay M. Kapranov
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S296
Context: The independent influence of pre-transplant MRD status on the results of allogeneic hematopoietic stem cell transplantation (allo-HSCT) is now being widely reported. The genetic and immunophenotypic diversity of AML is a problem for monitori
Autor:
Maria V. Nareyko, Yulia Davydova, Larisa A. Kuzmina, Z V Konova, N N Popova, Elena N. Parovichnikova, Irina V. Galtseva, Olga S. Starikova, Ekaterina Mikhaltsova, Valery G. Savchenko, Nikolay M. Kapranov, Mikhail Drokov, Anna Dmitrova
Publikováno v:
Transplant immunology. 65
Granzyme B is known to be a serine protease contained in granules of cytotoxic T cells. We have previously reported an influence of granzyme B expression in T regulatory cells (Tregs) on the risk of acute graft versus host disease (GVHD) onset. Howev
Autor:
Anna Dmitrova, Mikhail Drokov, V A Vasilyeva, Olga S. Starikova, Maria Dovidenko, Valeriy G. Savchenko, Nikolay M. Kapranov, Ulyana V. Maslikova, Ekaterina Mikhaltsova, Z V Konova, N N Popova, Julia O. Davydova, Olga Koroleva, Elena N. Parovichnikova, Irina V. Galtseva, Larisa A. Kuzmina, Hunan Julhakyan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S187
Context One of the main causes of treatment failure after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for acute leukemia (AL) patients is the disease relapse. Minimal residual disease (MRD) detected by multiparameter flow cytometry
Autor:
Mikhail Yu. Drokov, Ulyana V. Maslikova, N N Popova, Z V Konova, Tatiana I. Lobanova, Irina V. Galtseva, Ekaterina Mikhaltsova, V A Vasilyeva, Olga Koroleva, Elena N. Parovichnikova, Larisa A. Kuzmina, Julia O. Davydova, Olga S. Starikova, Maria V. Nareyko, Valeriy G. Savchenko, Ekaterina I. Usikova, Nikolay M. Kapranov, Anna Dmitrova
Publikováno v:
Blood. 134:4562-4562
Introduction. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) could be curative for acute myeloid leukemia (AML) patients. However, the disease relapse after allo-HSCT lead to poor outcomes almost in all cases. Minimal residual disease
Autor:
Olga S. Starikova, N N Popova, V A Vasilyeva, Olga Koroleva, Mikhail Yu. Drokov, Anna Dmitrova, Ulyana V. Maslikova, Z V Konova, Ekaterina Mikhaltsova, Maria V. Dovydenko, Valery G. Savchenko, Elena N. Parovichnikova, Ekterina Usikova, Larisa A. Kuzmina
Publikováno v:
Blood. 134:1987-1987
Background: Nutritional problem is a key aspect of all severe diseases that always "keep in the shadows". There are different factors, such as intensive chemotherapy, constant nausea, severe infections, time for donor search that affect nutritional s
Autor:
Z V Konova, Maria V. Dovydenko, Mikhail Yu. Drokov, Ekaterina Mikhaltsova, Denis V. Kamelskih, Ulyana V. Maslikova, Olga S. Starikova, Larisa A. Kuzmina, Olga Koroleva, Elena N. Parovichnikova, Valeriy G. Savchenko, N N Popova, Anna Dmitrova, Michael Maschan, V A Vasilyeva, Tatiana V. Gaponova
Publikováno v:
Blood. 134:5648-5648
Introduction In most cases, haploidentical stem cell transplantation (haplo-HSCT) with negative depletion of α/β(+) T cells and CD19+ B lymphocytes from the graft is used to treat pediatric patients. The results are promising. However, the results